https://www.selleckchem.com/products/am580.html
Vulnerable plaques are the primary cause of acute coronary syndrome (ACS). The association between in-vivo plaque vulnerability and adiponectin levels in ACS still remains to be determined. The purpose of this study was to investigate the correlation between adiponectin levels and vulnerable plaque features in ACS patients. We enrolled 107 ACS patients admitted to our institution; 83 with Non-ST elevation ACS (NSTE-ACS) and 24 with ST-elevation myocardial infarction (STEMI). Adiponectin levels were measured in these patients. Coronary ang
Beğen
Yorum Yap
Paylaş
